Unknown

Dataset Information

0

Synthesis of Inorganic Pyrophosphatase-Nanodiamond Conjugates Resistant to Calcium and Fluoride.


ABSTRACT: Pyrophosphate arthropathy is the mineralization defect in humans caused by the deposition of microcrystals of calcium pyrophosphate dihydrate in joint tissues. As a potential therapeutic strategy for the treatment of pyrophosphate arthropathy, delivery of exogenous pyrophosphate-hydrolyzing enzymes, inorganic pyrophosphatases (PPases), to the synovial fluid has been suggested. Previously, we synthesized the conjugates of Escherichia coli PPase (Ec-PPase) with detonation synthesis nanodiamonds (NDs) as a delivery platform, obtaining the hybrid biomaterial retaining high pyrophosphate-hydrolyzing activity in vitro. However, most known PPases including Ec-PPase in the soluble form are strongly inhibited by Ca2+ ions. Because synovial fluid contains up to millimolar concentrations of soluble calcium, this inhibition might limit the in vivo application of Ec-PPase-based material in joint tissues. In this work, we proposed other bacterial PPases from Mycobacterium tuberculosis (Mt-PPase), which are resistant to the inhibition by Ca2+ ions, as an active PPi-hydrolyzing agent. We synthesized conjugates of Mt-PPase with NDs and tested their activity under various conditions. Unexpectedly, conjugates of both Ec-PPase and Mt-PPase with aminated NDs retained significant hydrolytic activity in the presence of well-known mechanism-based PPase inhibitors, fluoride or calcium. The incomplete inhibition of PPases by fluoride or calcium was found for the first time.

SUBMITTER: Valueva AV 

PROVIDER: S-EPMC7114608 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis of Inorganic Pyrophosphatase-Nanodiamond Conjugates Resistant to Calcium and Fluoride.

Valueva Anastasiya V AV   Romanov Roman S RS   Vorobyeva Nataliya N NN   Kurilova Svetlana A SA   Rodina Elena V EV  

ACS omega 20200320 12


Pyrophosphate arthropathy is the mineralization defect in humans caused by the deposition of microcrystals of calcium pyrophosphate dihydrate in joint tissues. As a potential therapeutic strategy for the treatment of pyrophosphate arthropathy, delivery of exogenous pyrophosphate-hydrolyzing enzymes, inorganic pyrophosphatases (PPases), to the synovial fluid has been suggested. Previously, we synthesized the conjugates of <i>Escherichia coli</i> PPase (Ec-PPase) with detonation synthesis nanodiam  ...[more]

Similar Datasets

| S-EPMC7178341 | biostudies-literature
| S-EPMC3912225 | biostudies-literature
| S-EPMC2829273 | biostudies-literature
| S-EPMC2818162 | biostudies-literature
| S-EPMC8073611 | biostudies-literature
| S-EPMC3444275 | biostudies-literature
| S-EPMC5768878 | biostudies-other
| S-EPMC10311840 | biostudies-literature
| S-EPMC3509969 | biostudies-literature
| S-EPMC317221 | biostudies-literature